Anthem Biosciences Share price target & analyst calls
₹805.55-2.95 (-0.36%)
Avg 1-year target
All 4 long-term calls are BUY₹1,012.525.7% above today's price
Anthem Biosciences' average 1-year share price target is ₹1,012.5, the average of 4 advisors' latest targets. Targets range from ₹1,000 to ₹1,050.
Latest: Vikas Sethi, Sethi Finmart ₹1,000 · 19 Oct 2026
4
4 BUY · 0 SELL, all horizons
4
with an active 1Y target
53%
9 of 17 closed calls hit
23
all horizons, open and closed
Watch ANTHEM for new buy/sell callsGet alertsSee 44 Pharmaceuticals & Biotechnology sector analyst picks
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
Anthem Biosciences target price by brokerage
Each advisor's latest 1-year target · 4 advisors · tap a row for the call
- VSVikas Sethi, Sethi FinmartLow19 Oct 2026 · via Zee Business (Live)₹1,000+24.1%
- ACAshish Chaturmohta, JM FinancialLow8 Oct 2026 · via CNBC Awaaz.₹1,000+24.1%
- JIJefferies IndiaHigh21 Aug 2026 · via Zee Business (Live)₹1,050+30.3%
- AJAnshul Jain, Lakshmishree Investment and SecuritiesLow22 Jul 2026 · via Business Today₹1,000+24.1%
All tips (23)
VSbyVikas Sethi, Sethi Finmart+24.1% to target
1 Year · 12 mo left · 19 Oct 2026 · entry ₹819 · via Zee Business (Live)P&L -1.6%
ACbyAshish Chaturmohta, JM Financial+24.1% to target
1 Year · 12 mo left · 8 Oct 2026 · entry ₹872 · via CNBC Awaaz.P&L -7.6%
JIbyJefferies India+30.3% to target
1 Year* · 10 mo left · 21 Aug 2026 · entry ₹893 · via Zee Business (Live)P&L -9.8%
AJbyAnshul Jain, Lakshmishree Investment and Securities+24.1% to target
1 Year* · 9 mo left · 22 Jul 2026 · entry ₹781 · via Business TodayP&L +3.1%
SSbySiddharth Sedani, Anand RathiTarget hit
1 Year · 9 Jul 2026 · entry ₹760 · via Zee Business (Live)exit ₹930
BCbyBOB Capital MarketsTarget hit
1 Year* · 21 May 2026 · entry ₹769.1 · via Institutional / Brokerage Researchexit ₹900
BCbyBOB Capital MarketsTarget hit
1 Year* · 27 Feb 2026 · entry ₹701.25 · via Institutional / Brokerage Researchexit ₹835
ACbyAshish Chaturmohta, JM FinancialStop-loss hit
1 Year · 26 Aug 2026 · entry ₹894.1 · via CNBC Awaaz.exit ₹830
PLbyPrabhudas LilladherTarget hit
1–3 Months* · 9 Jul 2026 · entry ₹748 · via Economic Times New Stock Recosexit ₹850
VSbyVikas Sethi, Sethi FinmartTarget hit
1–3 Months · 8 Jun 2026 · entry ₹768 · via Zee Business (Live)exit ₹810
ICbyIDBI CapitalTarget hit
1–2 Weeks* · 1 Sept 2026 · entry ₹912 · via IDBI Capital Research Calls Telegramexit ₹958
AKbyAshish Kyal, Waves Strategy AdvisorsTarget hit
1–2 Weeks* · 26 Aug 2026 · entry ₹928 · via CNBC Awaaz.exit ₹955
AKbyAshish Kyal, Waves Strategy AdvisorsTarget hit
1–2 Weeks* · 26 Aug 2026 · entry ₹920 · via CNBC Awaaz.exit ₹965
AJbyAastha Jain, Hem SecuritiesTarget hit
1–2 Weeks* · 17 Aug 2026 · entry ₹890.55 · via Zee Business (Live)exit ₹930
ABbyAshish Bahety, Profitmart SecuritiesStop-loss hit
1–2 Weeks* · 2 Sept 2026 · entry ₹938.05 · via CNBC Awaaz.exit ₹910
SRbySiddharth Rai MangalaExpired
Intraday · 7 Oct 2026 · entry ₹892 · via Zee Business (Live)exit ₹887.5
* Horizon not stated by the source; assumed from how far the target is from the entry price.
Compare Pharmaceuticals & Biotechnology targets
Most-covered stocks in the sector · average 1-year target
- DRREDDYDr. Reddy's Laboratories Limited₹1,346+8.1% · 19 calls
- CIPLACipla Ltd.₹1,524+16.0% · 17 calls
- SUNPHARMASun Pharmaceutical Industries Ltd.₹2,226+27.5% · 15 calls
- BIOCONBiocon Ltd₹485+44.8% · 12 calls
- LUPINLupin Limited₹2,576+31.2% · 12 calls
- ANTHEM· this stockAnthem Biosciences Limited₹1,013+25.7% · 4 calls